ECG Assessments During The Development Of Oncology Compounds
Thijs van Iersel, MD Borje Darpo, MD, PhD Gerd Arold, MD
CARDIONCOLOGY.ORG ABSTRACT:
Assessment of ECGs during the development of oncology compounds is challenging.
Extraction of ECG data using the High Precision QT technique of iCardiac and Exposure Response analysis can result in a conclusive ECG assessment with a limited number of volunteers.
This approach represents a unique opportunity for cardiac safety assessment by ECG.
© All rights reserved
image source: https://www.medicalnewstoday.com/content/images/articles/326/326208/ecg-on-a-screen.jpg